Jeffrey Selman > DLA Piper LLP (US) > San Francisco, United States > Lawyer Profile

DLA Piper LLP (US)
SAN FRANCISCO, CA 94105-2933
United States

Work Department

Corporate; Life Sciences


Chair of SPAC Transactional Practice


Jeffrey C. Selman represents emerging and middle-market public and private technology and life sciences companies and investors on their formation, equity and debt financing, mergers and acquisitions, licensing, restructurings, board and management issues, and general corporate and commercial transactional matters. He has particular experience advising on the creation and funding of special purpose acquisition companies (SPACs), as well as advising on the use of SPACs as a means of taking companies public.

He has represented companies in a wide range of industries, including software, social networking, mobile device applications, interactive gaming and entertainment, media, semiconductor, network equipment, biotech, medical devices, geothermal, solar, battery, energy storage, metals and emerging automotive technology.


J.D., Columbia University School of Law; A.B., Stanford University

Lawyer Rankings

United States > Finance > Capital markets: equity offerings

DLA Piper LLP (US) has a large US capital markets team spread across its multiple offices, best known for mid-cap deals. The large team has enabled it to develop an impressively wide-ranging list of engagements from issuers and underwriters. The department has landed a series of headline SPAC offering engagements, thanks to the efforts of Jeffrey Selman in San Francisco. Head of the capital markets group Christopher Paci has also played a pivotal role in developing the firm’s presence in Latin America transactions.